Peptide Therapy at a Medspa: What It Is, What It Costs, and Who It’s For

peptide therapy medspa

Peptide therapy is one of the fastest-growing service categories at forward-thinking medspas — and one of the most misunderstood. Patients come in having read about BPC-157, CJC-1295, Ipamorelin, and Thymosin Alpha-1 on longevity podcasts or biohacking forums, often with a general sense that peptides are beneficial and a specific confusion about what any of them actually do, what they cost, and whether they need a medical professional to administer them. This guide cuts through the noise.

I work with medspas that are building peptide therapy into their service menu as both a standalone offering and a complement to GLP-1 weight loss programs, aesthetic treatments, and IV therapy. Done well, peptide therapy is a high-margin, high-retention service with a loyal patient demographic. Done poorly — with vague protocols, untrained staff, and overpromised outcomes — it creates refund requests and reputation damage. Here is what you need to know.

1. What Peptide Therapy Actually Is

Peptides are short chains of amino acids — essentially smaller versions of proteins — that act as signaling molecules in the body, directing biological processes including hormone release, tissue repair, immune function, and cellular communication. Therapeutic peptides are either identical to naturally occurring peptides in the body or synthetic analogs designed to mimic or amplify their function.

Peptide therapy in a medspa context refers to the supervised use of pharmaceutical-grade peptides — typically administered via subcutaneous injection, though some are available in oral or intranasal form — to achieve specific clinical outcomes: body composition improvement, recovery acceleration, immune modulation, cognitive enhancement, gut repair, or anti-aging effects at a cellular level.

Unlike GLP-1 medications, most peptides used in wellness contexts are not FDA-approved drugs — they are compounded preparations, research chemicals sold for investigational use, or supplements. This regulatory distinction is critical for both patient safety and how medspas can legally market and administer these substances. A reputable medspa offering peptide therapy will have clear protocols, a licensed prescriber involved in patient selection, and documented sourcing from licensed US compounding pharmacies.

2. The Most Commonly Offered Peptides at Medspas

The peptide landscape is extensive, but a relatively short list of peptides accounts for the majority of medspa use:

Sermorelin / CJC-1295 + Ipamorelin: Growth hormone-releasing peptides that stimulate the pituitary gland to produce more natural growth hormone. Commonly used for body composition (increased lean mass, decreased fat), improved sleep quality, and recovery. These are among the most established and widely used peptide protocols at medspas.

BPC-157 (Body Protection Compound 157): A gut-derived peptide with significant evidence in animal models for tissue healing, gut repair, and anti-inflammatory effects. Used by patients recovering from injuries, those with gut permeability issues, and athletes seeking accelerated recovery. Human clinical data is limited compared to animal research, which is an honest caveat for patient conversations.

Thymosin Alpha-1 (Ta1): An immune-modulating peptide used for immune system support, particularly in patients with chronic illness, immunodeficiency, or who want to optimize immune resilience. Some patients use it for long-COVID symptom management, though evidence in this area is emerging rather than established.

PT-141 (Bremelanotide): A melanocortin receptor agonist with FDA approval in a specific branded form for hypoactive sexual desire disorder in premenopausal women. Compounded versions are widely used at medspas for both female and male sexual function optimization. One of the few peptides with an approved pharmaceutical analog.

Semaglutide and Tirzepatide: Technically GLP-1 receptor agonist peptides — the same class. Often discussed separately in medspa contexts, but worth noting that the GLP-1 revolution is fundamentally a peptide therapy story.

3. What Peptide Therapy Costs at a Medspa

Peptide therapy pricing varies significantly based on the specific peptide, dose, administration route, and whether the cost includes prescriber oversight, injection training, and follow-up monitoring. Here are realistic ranges for common protocols:

• Sermorelin or CJC-1295 + Ipamorelin: est. $200–$400 per month for compounded injectable plus prescriber management
• BPC-157 injectable protocol: est. $150–$300 per month depending on dose and duration
• Thymosin Alpha-1 injection course: est. $300–$600 for a four to eight week course
• PT-141 per-use vials: est. $50–$100 per vial with prescription
• Comprehensive peptide protocol (multiple peptides stacked): est. $400–$800 per month depending on stack complexity
• Initial consultation and panel: est. $150–$350 one-time for labs, assessment, and protocol design

These prices reflect legitimate medical-grade compounded peptides through licensed providers. Significantly lower pricing — particularly from online-only sources without prescriber involvement — is almost always a signal of unregulated sourcing, which carries safety and legal risk. For a full financial picture of what peptide services contribute to practice revenue, the medspa revenue calculator allows you to model margin at different service mixes.

4. Who Is a Good Candidate for Peptide Therapy

The patient who gets the most consistent value from peptide therapy at a medspa tends to share a few characteristics: they are health-conscious, generally already doing the basics well (sleep, exercise, adequate protein), they have a specific outcome goal rather than a vague interest in “being healthier,” and they are willing to commit to a protocol duration long enough to see results — typically a minimum of two to three months for most growth hormone peptide protocols.

Specific patient profiles that consistently respond well to common peptide protocols:

• Adults 35–55 experiencing age-related changes in body composition, recovery, or sleep quality who want to address root causes rather than symptoms
• Athletes or active patients dealing with injury recovery or performance optimization goals
• Patients with gut permeability concerns, chronic low-grade inflammation, or a history of GI issues that have not fully resolved
• Patients who have completed or are undergoing GLP-1 weight loss programs and want to optimize muscle preservation and recovery
• Patients with immunocompromise or recurrent illness seeking evidence-informed immune support

5. Who Should Not Start Peptide Therapy

Contraindications and cautions vary by peptide, but some general red flags that require careful prescriber evaluation before proceeding: active malignancy or personal history of cancer (growth hormone stimulation is contraindicated with active or recent cancer), pregnancy or breastfeeding for most injectable peptides, autoimmune conditions for some immune-modulating peptides, known sensitivity to peptide components, and active systemic infection for immunomodulatory protocols.

The regulatory landscape also creates a practical consideration: because most peptides are compounded rather than FDA-approved, the long-term safety data that exists for approved pharmaceuticals does not exist for most peptides in human populations. An honest prescriber will communicate this clearly and help the patient weigh benefit against the inherent uncertainty of working with compounds that have limited human clinical trial data, even when the mechanistic rationale is strong.

6. What Results to Realistically Expect

Setting accurate expectations is the single most important thing a medspa can do for peptide therapy patient satisfaction. Here is what the evidence and clinical experience suggest for commonly used protocols:

Growth hormone peptides (CJC-1295 + Ipamorelin): most patients notice improved sleep quality in the first two to four weeks. Body composition improvements — increased lean mass, reduced body fat — typically require est. three to six months of consistent use. Patients who expect dramatic body transformation in the first month are likely to be disappointed.

BPC-157: injury recovery and gut symptom relief are reported by many patients within two to four weeks of a therapeutic dose protocol. Results vary significantly based on the underlying condition being treated and individual response.

Thymosin Alpha-1: immune-related outcomes are difficult to measure subjectively — patients often report fewer illnesses over a season, or reduced symptom duration when ill. Objective immune panel improvements can sometimes be documented with pre and post labs.

PT-141: effects on sexual desire and response are typically experienced within one to two hours of administration, making this one of the more immediately feedback-rich peptide protocols from a patient experience standpoint.

7. Legal and Regulatory Considerations for Medspa Peptide Programs

The regulatory status of peptides at medspas is genuinely complex and has been shifting. In 2023 and 2024, the FDA took action against several compounded peptides — including BPC-157 and TB-500 — designating them as “bulk drug substances that may not be compounded” under Section 503A and 503B. This removed them from the legal compounding pathway that medspas had been using. The status of specific peptides changes as FDA enforcement priorities and designations evolve.

Before adding any peptide to your medspa program, confirm with your compounding pharmacy and a healthcare attorney that the specific peptide is currently in a legal compounding pathway. Operating with peptides on the FDA’s restricted list creates significant liability — not just regulatory, but clinical and commercial if a patient experiences an adverse event. This is not an area where it is acceptable to be vague about compliance status. The medspa marketing resource library has additional guidance on how to position peptide programs accurately in marketing materials given the regulatory complexity.

8. How to Market Peptide Therapy Responsibly and Effectively

Peptide therapy marketing works best when it is educational, specific, and honest about what the evidence does and does not support. The patients who convert to peptide programs are research-literate — they have already listened to three podcasts on the topic. Marketing that oversimplifies or overpromises loses credibility with this audience faster than with almost any other patient segment.

Effective peptide marketing content addresses specific outcomes (recovery, sleep, body composition, immune function) with the evidence that supports those outcomes, is transparent about the regulatory and research status of the peptides offered, positions the prescriber’s clinical judgment as a key differentiator (not just “we offer peptides”), and uses patient testimonials carefully — avoiding specific disease claims that would constitute unapproved drug advertising.

Outcome language to use: “patients in our program have reported improved sleep quality, reduced recovery time, and favorable changes in body composition over a three-month protocol.” Claims to avoid: “this peptide cures inflammation,” “this protocol reverses aging,” or any language that implies the peptide treats a specific disease.

9. Building Peptide Therapy Into a Larger Medspa Program Architecture

The medspas doing peptide therapy best are not offering it as a standalone vending machine service. They are integrating it into a broader longevity or optimization program that includes baseline labs, body composition monitoring, nutritional assessment, and regular provider check-ins — creating a clinical relationship that generates strong retention and high lifetime patient value.

Natural integration points for peptide therapy in a medspa program architecture: as a complement to GLP-1 programs (growth hormone peptides for muscle preservation during weight loss), alongside IV therapy programs (Thymosin Alpha-1 as an immune add-on to IV drips), and as part of a male or female hormone optimization program where peptides complement HRT. Each integration point creates a higher-value patient relationship and justifies the clinical infrastructure required to do these programs safely.

10. Starting a Peptide Therapy Program at Your Medspa: The Right Sequence

For medspa operators considering adding peptide therapy: the right sequence is compliance first, then clinical protocol, then marketing. Not the reverse. Confirm which peptides are in a legal compounding pathway in your state and under current FDA guidance. Establish your prescriber relationship and written protocols for each peptide offered. Train your clinical staff on injection technique, patient monitoring, and adverse event recognition. Then build your marketing around the specific, legally compliant program you have designed.

Rushing to market without the compliance and clinical infrastructure in place is how medspas end up in regulatory trouble or handling patient adverse events without a documented protocol to reference. A free consultation with our team can help you think through how to structure and market a peptide program that is both defensible and commercially successful.